SCHEMBL25719657

SCHEMBL25719657

CC(=O)OC(C)c1oc2c(O)c(O)c(O)c(O)c2c1C(=O)C1=CC(Br)=C(O)C(Br)=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22072522 0.76 EYA3 (0.45) —
SCHEMBL24267018 0.71 EYA3 (0.36) —
SCHEMBL26211957 0.68 EYA3 (0.42) —
SCHEMBL24103744 0.63 EYA3 (0.42) —
SCHEMBL24102960 0.63 EYA3 (0.42) —
SCHEMBL22072500 0.62 EYA3 (0.58) —
SCHEMBL24267020 0.62 EYA3 (0.35) —
SCHEMBL24266787 0.61 EYA3 (0.36) —
SCHEMBL24267353 0.59 ALDH1A1 (0.39) —
SCHEMBL26211199 0.58 CYP2C19 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023098872-A1 CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2023-06-08 — — WO disclosed
Send feedback